Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for postoperative sleep disorders in thyroid cancer surgery
ChiCTR2600125182Phase 4Not yet recruiting
- Sponsor
- Zunyi Medical University Affiliated Hospital
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in sleep disorder and thyroid cancer (3 arms), sponsored by Zunyi Medical University Affiliated Hospital. Primary endpoint: Athens Insomnia Scale (AIS). Planned start May 2026; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
sleep disorderthyroid cancer
Beyond the preview
Go deeper on ChiCTR2600125182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600125182.